AI assistant
DEXCOM INC — Director's Dealing 2019
Jun 5, 2019
30198_dirs_2019-06-04_444dc2d9-d5ee-4b44-ac74-11e8f5024ab7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2019-05-31
Reporting Person: AUGUSTINOS NICHOLAS (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-31 | Common Stock | A | 2676 | $0.001 | Acquired | 10478 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 14362 | Indirect |
Footnotes
F1: The RSU Award was granted on May 31, 2019 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting.
F3: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.